Xen Biofluidx has an integrated product development approach for inert nanoparticles. Through the sophisticated production and identification of a gene and expression of the respective protein — from creating conjugates of antibodies to surface chemistry optimization — we deliver high-impact assays. These assays are integrated into our point-of-care device, allowing us to develop products that meet or exceed our customers’ expectations.
Simplifying Complexity. Delivering Impact.
Redefining point-of-care testing with breakthrough technologies delivering laboratory-grade sensitivity, accuracy, speed, and reliability for real-world diagnostics.
Focus Areas
Transforming Point-of-Care Diagnostics
Xen Biofluidx Inc. is redefining point-of-care testing with breakthrough diagnostic technologies that deliver laboratory-grade performance. Our CliniHUB HiSENSE platform integrates advanced innovations to enable highly sensitive, precise, and rapid disease detection and prognosis — right at the point of care.
CliniHUB HiSENSE system brings together expertise in nanoparticle surface chemistry, antibody engineering, optoelectronics, microfluidics, assay development, and lyophilization to create assays with minimal non-specific binding and low background signal. Combined with high-sensitivity detection, it delivers performance that exceeds hospital clinical analyzers.
Why Choose Xen Biofluidx
20+ Years of Contract Design
Two decades of proven partnership with global leaders in pharma and diagnostics, including Roche and Bio-Rad. We turn complex challenges into commercial-ready solutions.
Integrated Product Development
From concept to clinic — a single, seamless pipeline. We carry your idea through every stage of development, eliminating handoff delays and ensuring uncompromised quality at launch.
Room-Temperature Stable Reagents
Our fully integrated magnetic, fluorescent, and TRF pellets remain stable for a full year at room temperature — eliminating cold-chain dependency and reducing logistics costs worldwide.
Patented Technologies
A robust portfolio of proprietary and licensed patents protects our edge in point-of-care detection of biomolecules at ultra-low concentrations in blood and other biological fluids.
Laboratory-Grade Sensitivity
Our CliniHUB HiSENSE platform delivers analytical performance that matches — and often exceeds — central hospital analyzers, bringing reference-lab precision to the bedside, clinic, and field.
Cross-Disciplinary Expertise
Surface chemistry, antibody engineering, optoelectronics, microfluidics, assay development, and lyophilization — all under one roof. One team. One vision. One accelerated path to market.
Our Core Capabilities
Proprietary Inert Surface Chemistries for Magnetic & TRF Nanoparticle Platforms
Xen Magnetic Beads are high-performance, QA-controlled particles designed for biomolecular separation, diagnostics, and automated workflows. Engineered for speed, reproducibility, and scalability, we deliver consistent results across research, OEM, and regulated diagnostic applications.
Advanced Protein and Antibody Engineering
Our catalog contains primary antibodies covering a variety of research areas and scientific research applications. This includes recombinant monoclonal, monoclonal, and polyclonal antibodies, curated around specific research areas including immuno-oncology, cardiovascular biology, neuroscience, and infectious disease. These antibodies can be used for a variety of applications including western blot, multiplex immunofluorescence, flow cytometry, immunoprecipitation, lateral flow, and more.
Integrated High-Sensitivity Assay Development Using the TRF Digital Reader
Xen Biofluidx delivers a high-performance, time-resolved fluorescence (TRF) point-of-care digital reader platform engineered for rapid, quantitative diagnostics with laboratory-grade accuracy. Integrating advanced optical detection allows precision signal processing. We support end-to-end assay development and manufacturing — enabling partners to accelerate the translation of biomarker discoveries into clinically actionable diagnostics with exceptional performance.
Next-Generation Microfluidics-Based Device Systems
The future of diagnostics — connected, precise, and accessible. Our next-generation microfluidic platforms integrate sample preparation, reagent handling, and high-sensitivity detection into a single compact device. With seamless connectivity and cutting-edge performance, Xen Biofluidx is shaping the next generation of point-of-care diagnostics — bringing reference-lab capabilities directly to the bedside, clinic, and field.
Our Clients
Trusted by leading pharmaceutical and diagnostic companies around the world.
Ready to bring your idea to life?
Partner with us for integrated product development from concept to commercialization.